NAT-MONTELUKAST
Identification of Nat-Montelukast
| No description |
Google image searchProduct monograph
Active ingredient
montelukast (montelukast sodium), 4 MG
DIN: 02522101
Dosage form(s): TABLET (CHEWABLE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 19-DEC-2022
ATC:
- R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
- R03D — OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD)
- R03DC — Leukotriene receptor antagonists (ATC, ATC/DDD)
- R03DC03 — MONTELUKAST (ATC/DDD)
Reference brand drug: Singulair
Pharmaceutical standard: MFR
